NEOTROPIX
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. It develops NTX010, a naturally-occurring virus that attacks and kills neuroendocrine cancers, such as small cell lung cancer, small cell carcinomas originating in other organs, carcinoid, neuroblastoma, and certain other neuroendocrine cancers. The company was founded in 2003 and is headquartered in Malvern, Pennsylvania.
NEOTROPIX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.neotropix.com
Total Employee:
1+
Status:
Active
Contact:
610-296-8660
Email Addresses:
[email protected]
Total Funding:
11.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box Organization Schema IPv6
Current Employees Featured
Founder
Investors List
VIMAC Milestone Medical Fund
VIMAC Milestone Medical Fund investment in Series A - Neotropix
The Aurora Funds
The Aurora Funds investment in Series A - Neotropix
Quaker BioVentures
Quaker BioVentures investment in Series A - Neotropix
Official Site Inspections
http://www.neotropix.com
- Host name: 104.21.2.240
- IP address: 104.21.2.240
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Neotropix"
Neotropix | Home
Neotropixâ„¢ Inc. develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers, such as small cell lung cancer and neuroblastoma.See details»
About us - Neotropixâ„¢ Inc
Neotropixâ„¢ Inc. develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers, such as small cell lung cancer and neuroblastoma.See details»
Neotropix - Crunchbase Company Profile & Funding
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. It develops NTX010, a naturally …See details»
Neotropix, Inc - LinkedIn
Neotropixâ„¢ Inc. develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers, such as small cell lung cancer and neuroblastoma.See details»
Neotropix Company Profile 2024: Valuation, Funding & Investors
Neotropix is headquartered in Malvern, PA. What is the size of Neotropix? Neotropix has 9 total employees. What industry is Neotropix in? Neotropix’s primary industry is Biotechnology. Is …See details»
Neotropix Inc - Company Profile and News - Bloomberg Markets
The Company develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers such as small cell lung cancer and neuroblastoma. …See details»
Neotropix, Inc Company Profile | Malvern, PA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Neotropix, Inc of Malvern, PA. Get the latest business insights from Dun & Bradstreet.See details»
NEOTROPIX, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NEOTROPIX, INC. of Chester Springs, PA. Get the latest business insights from Dun & Bradstreet.See details»
Neotropix - Crunchbase
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment ofSee details»
Neotropix - Funding, Financials, Valuation & Investors - Crunchbase
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment ofSee details»
Neotropix - Overview, News & Similar companies | ZoomInfo.com
View Neotropix (www.neotropix.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Neotropix - Products, Competitors, Financials, Employees, …
Neotropix 1 is a virotherapy company, dedicated to the development and commercialization of virus-based therapies for the treatment of cancer and other diseases. Use the CB Insights …See details»
Scripps Research Team Solves Structure of "Beneficial" Virus
Oct 13, 2008 · The Senecavirus is a "new" virus, discovered several years ago by Neotropix Inc., a biotech company in Malvern, Pennsylvania. It was at first thought to be a laboratory …See details»
Neotropix, Inc. Receives FDA Approval To Begin Clinical ... - BioSpace
MALVERN, Pa., May 17 /PRNewswire/ -- Neotropix (TM), Inc., a biotechnology company developing oncolytic viruses for the treatment of cancer, announced today that the FDA has …See details»
Seneca Valley Virus, a Systemically Deliverable Oncolytic …
Nov 7, 2007 · Drs Reddy, Burroughs, Hayes, Idamakanti, and Hallenbeck and Mr Jones and Ms Skele are employees of Neotropix, Inc, hold stock in the company, and are performing …See details»
Neotropix, Inc. Announces Enrollment of Patients in National …
Neotropixâ„¢ Inc. is focused on the development of anti-cancer products that have a high degree of selectivity for tissues resulting in both therapeutic efficacy and an excellent safety and …See details»
Neotropix - Contacts, Employees, Board Members, Advisors
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment ofSee details»
765. Nature of Seneca Valley Virus (SW-001/NTX-010) RNA in
Neotropix is in Phase 1 clinical trials with a novel oncolytic virus known as Seneca Valley Virus (SVV-001/ NTX-010).See details»
Research programme: oncolytic virus therapeutics - Neotropix
Jun 16, 2011 · Neotropix was preclinically developing viral therapies for the potential treatment of cancer. Virotherapy is potentially more efficacious and less toxic than.See details»
Chris Kroeger - Partner @ The Aurora Funds - Crunchbase
Chris led or co-led syndicated investments in Cardioxyl Pharmaceuticals, Hyberbranch Medical, and. Neotropix, and led Auroras's investments in Cardiofocus and Paringenix.See details»